Presenting on "Gene therapy for neuroscience"
Junghae Suh, PhD, vice president, head of Gene Therapy Accelerator Unit, Biogen, Cambridge, MA, will speak at 10:00 CST on Thursday, January 27, 2022. This seminar is virtual and registration is required. Register for this seminar.
Abstract: Decades of biological research have unveiled the genetic cause of many debilitating diseases that affect the central nervous system (CNS). We are at a point where we aim to translate that knowledge into potential one-time treatment options and curative therapies. Gene therapy as a therapeutic modality is continuing to evolve and we have seen important advances propelling the field forward. However, additional focused innovation is needed to overcome the complex challenges in gene therapy for neurological diseases. Challenges regarding the delivery platform, cargo, vector production, and vector performance characterization as well as potential solutions to these challenges will be discussed.
Hosts: Professors Chao Zhou and Michael Vahey, Washington University in St. Louis
This seminar is virtual and registration is required. Register for this seminar.
If you are a member of the WashU community, login with your WUSTL Key to interact with events, personalize your calendar, and get recommendations.Login with WUSTL Key
If you are not a member of the WashU community, please login via one of the options below to interact with our calendar.